人CD46启动子真核表达载体的构建

为了构建人CD46（hCD46）启动子指导目的基因表达的真核表达载体,提取HeLa细胞基因组DNA,用PCR扩增出hCD46基因的启动子区域,序列分析结果表明其与GenBank中hCD46基因5’端某片段的同源性为99.9％。用此启动子替换pcDNA3EGFP中的CMV启动子,并在hCD46启动子和EGFP基因之间插入兔β-球蛋白基因第二内含子（RGI）,得到的重组表达载体转染CHO和SP2/0两种鼠源细胞,流式细胞术检测表明CHO细胞EGFP的表达量高于SP2/0细胞,表达特性与人体CD46相似;RGI可以增强EGFP的表达量,但不改变其表达的组织特异性,提示克隆的hCD46启动子可以用于研制模拟人体CD46基因表达特性的转基因小鼠。     

构建LEF1基因毛囊特异表达载体并稳定转染胎儿成纤维细胞

旨在构建内蒙古白绒山羊(Capra hircus)淋巴样增强因子-1(Lymphoid enhancer factor,LEF1)基因真核表达载体并转染胎儿成纤维细胞,获得稳定表达红色荧光蛋白及毛囊特异性表达LEF1的转基因细胞克隆。以pCDsRed2载体为基本骨架将LEF1基因亚克隆到KAP6-1启动子下游,连接红色荧光蛋白表达元件,构建LEF1基因毛囊特异表达载体pCDsRed-KL。外源表达载体以lipofectamineTM2000介导转染胎儿成纤维细胞,通过G418筛选获得稳定转染的细胞克隆。PCR鉴定外源基因在细胞基因组中的整合。测序显示构建的表达载体pCDsRed-KL序列中,LEF1基因正确连接在KAP6-1启动子下游,顺序连接CMV启动子和红色荧光蛋白基因,载体构建正确。脂质体介导的稳定转染效率约为14.0%,经G418筛选得到高效表达红色荧光蛋白转基因细胞克隆。PCR检测显示外源KAP6-1启动子和LEF1基因整合到胎儿成纤维细胞基因组中。     

大肠杆菌K88ac菌毛操纵子fae全基因的克隆、表达及生物学活性初步研究

目的：在体外克隆和表达猪肠产毒性大肠杆菌（ETEC）K88ae菌毛操纵子,触结构基因,并检测重组菌毛的相关生物学活性。方法：利用长PCR技术以猪ETECK88ae株C83902基因组DNA为模板扩增编码K88菌毛操纵子触基因,克隆入表达质粒载体pBR322,构建和筛选重组质粒pBR322-fae,转化至不含任何菌毛的大肠杆菌EP株;电镜观察重组菌表面菌毛表达情况;用热抽提法提纯表达的重组菌毛;用纯化菌毛免疫小鼠制备高效价抗血清;用SDS-PAGE和Western blot检测重组菌毛的抗原性,用细胞黏附和黏附抑制试验检测其生物学活性。结果和结论：在电镜下观察到重组菌表面大量表达K88ae菌毛,该重组菌与兔抗K88ae菌毛单因子阳性血清、鼠抗K88ac菌毛单克隆抗体均产生凝集反应;纯化菌毛经SDS-PAGE,结构单位菌毛呈单一的相对分子质量约26×10^3的蛋白条带;纯化菌毛免疫小鼠后可制备出高效价的鼠抗血清,玻板凝集试验和Western blot结果表明体外表达的K88ae菌毛具有与K88ae野生菌毛相同的抗原性;猪小肠上皮细胞系黏附和黏附抑制实验结果表明重组EP菌和野生菌株一样具有较强的黏附猪小肠上皮细胞系的能力,而且提纯重组菌毛制备出的鼠抗血清能有效抑制上述重组菌或野生菌株对猪小肠上皮细胞系的黏附结合。     

淋病奈瑟菌黏附机制的研究进展

淋病导致的公共卫生问题在世界范围内广泛存在.淋病奈瑟菌的唯一宿主是人类,该菌侵袭泌尿生殖道引起淋病.其感染的关键是黏附因子对黏膜细胞的黏附.淋病奈瑟菌主要黏附因子与细胞受体间的作用机制已经在细胞水平上研究得比较清楚,表达淋病奈瑟菌黏附因子受体的转基因动物可望成为淋病研究的合适动物模型,为深入研究淋病奈瑟菌的致病机制、研制淋病疫苗及新型治疗药物提供有效工具.     

细胞壁缺陷型淋病奈瑟菌cppB基因的检测

目的：了解细胞壁缺陷对淋病奈瑟菌隐蔽性质粒B基因（cppB）的影响。方法：用青霉素诱导林病奈瑟菌成L型,以非高渗液体培养基传代培养并获得L型纯培养物,用cppB基因特异性引物以聚合酶链反应（PCR）检测不同代次稳定L型纯培养物的cppB基因。结果：淋病奈瑟菌细菌型及其传1-4代的L型培养物具有cppB基因,传5代后的L型培养物不能检出cppB基因。结论：细胞壁缺陷可造成淋病奈瑟菌隐蔽性质粒丢失,导致cppB基因PCR检测漏诊。     

p150Sal2 在人卵巢癌细胞株中促进MX1 基因的表达

目的:研究p150Sal2在人卵巢癌细胞株中对MX1基因表达的影响。方法:将MX1基因的启动子克隆至带有Luciferase报告基因的pGL3-basic载体中,将其与p150Sal2表达载体用PEI介导的转染方法共转染至卵巢癌细胞株SKOV3,用双荧光素酶检测系统检测MX1启动子活性变化;将p150Sal2表达载体转染至卵巢癌细胞株ES-2,用western blot检测细胞中MX1基因的表达变化。结果:双荧光素酶检测系统检测MX1启动子活性被p150Sal2上调,western blot检测转染p150Sal2后细胞中MX1表达量增加。结论:p150Sal2在人卵巢癌细胞株中促进MX1基因的表达。     

p150Sa12在人卵巢癌细胞株中促进MX1基因的表达

目的：研究p150Sa12在人卵巢癌细胞株中对MX1基因表达的影响。方法：将MX1基因的启动子克隆至带有Luciferase报告基因的pGL3-basic载体中,将其与p150Sa12表达载体用PEI介导的转染方法共转染至卵巢癌细胞株SKOV3,用双荧光素酶检测系统检测MX1启动子活性变化;将p150Sa12表达载体转染至卵巢癌细胞株ES-2,用western blot检测细胞中MX1基因的表达变化。结果：双荧光素酶检测系统检测MX1启动子活性被p150Sa12上调,westemblot检测转染p150Sa12后细胞中MX1表达量增加。结论：D150Sa12在人卵巢癌细胞株申促进MX1基因的表达。     

FLT-1启动子在血管内皮细胞中特异生物活性的检测及其意义

目的:构建带有组织特异性FLT-1启动子的真核表达载体,检测其在转染的人脐静脉内皮细胞（HUVEC）中对荧光素酶报告基因表达的驱动能力。方法：采用PCR扩增FLT-1启动子,插入到pGL3-Basic-luc载体中,构建携带FLT-1启动子的真核表达载体pGL3-FLT-Basic-luc,经脂质体法转染HUVEC、HepG2、NIH3T3和HEK293细胞,于转染48h后采用双荧光报告系统检测荧光素酶表达活性。 结果:酶切及测序证实构建的pGL3-FLT-Basic-luc载体中含有序列正确的FLT-1基因启动子,双荧光报告系统检测显示,转染的HUVEC细胞其荧光素酶活性明显高于HEK293细胞（P<0.01）,而转染的HepG2和NIH3T3细胞中未检测出荧光素酶表达。结论:克隆的FLT-1启动子具有较高的血管内皮特异性转录活性,可作为血管疾病靶向基因治疗的启动子来源。图     

组织特异性启动子介导的反义FGF8b RNA对前列腺癌细胞生长增殖能力的影响

利用启动子的组织特异性和治疗基因组织特异表达的特点 ,设计出前列腺癌靶向基因治疗的新方案 .利用DNA重组技术将前列腺组织特异性启动子 (probasin基因启动子 )和在前列腺癌细胞中高表达成纤维细胞生长因子 (FGF) 8b反义cDNA克隆到逆转录病毒载体pSIR中构建成重组体PB 反义FGF8b pSIR .经转染包装细胞PT 6 7后将产生的复制缺陷型逆转录病毒体外感染前列腺癌细胞系PC 3M ,体外检测其生长增殖和侵袭转移能力的变化 .结果表明 ,与对照组相比 ,前列腺癌细胞感染产生反义FGF8bRNA的逆转录病毒后生长速度减慢 ,集落形成能力下降 ,体外侵袭转移能力降低 (P <0 0 1) .体外试验表明 ,前列腺组织特异性启动子介导的反义FGF8bRNA可有效降低前列腺癌细胞的体外生长增殖和转移能力 ,这为体内靶向前列腺癌基因治疗奠定了可靠的基础 .     

FLT-1启动子在血管内皮细胞中特异生物活性的检测及其意义

目的:构建带有组织特异性 FLT-1 启动子的真核表达栽体,检测其在转染的人脐静脉内皮细胞(HUVEC)中对荧光素酶报告基因表达的驱动能力.方法:采用PCR扩增FLT-1启动子,插入到pGL3-Basic-luc载体中,构建携带FLT-1启动子的真核表达载体pGL3-FLT-Basic-luc,经脂质体法转染HUVEC、HepG2、NIH3T3和HEK293 细胞,于转染48h后采用双荧光报告系统检测荧光素酶表达活性.结果:酶切及测序证实构建的pGL3-FLT-Basic-luc栽体中含有序列正确的FLT-1基因启动子,双荧光报告系统检测显示,转染的HUVEC细胞其荧光素酶活性明显高于HEK293细胞(P<0.01),而转染的HepG2和NIH3T3细胞中未检测出荧光素酶表达.结论:克隆的FLT-1启动子具有较高的血管内皮特异性转录活性,可作为血管疾病靶向基因治疗的启动子来源.     

Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence

Pili of Neisseria gonorrhoeae mediate binding of the bacteria to human host cells. Membrane cofactor protein (MCP or CD46), a human cell-surface protein involved in regulation of complement activation, acts as a cellular pilus receptor. In this work, we examined which domains of CD46 mediate bacterial adherence. The CD46 expression was quantified and characterized in human epithelial cell lines. N. gonorrhoeae showed the highest adherence to ME180 cells, which have BC1 as the dominant phenotype. The BC isoforms of CD46 were expressed in all cell lines tested. The adherence was not enhanced by high expression of other isoforms, showing that the BC domain of CD46 is important in adherence of N. gonorrhoeae to human cells. To characterize the pilus-binding site within the CD46 molecule, a set of CD46–BC1 deletion constructs were transfected into COS-7 cells. Piliated N. gonorrhoeae attached well to CD46–BC1-expressing COS-7 cells. We show that the complement control protein repeat 3 (CCP-3) and the serine–threonine–proline (STP)-rich domain of CD46 are important for efficient adherence to host cells. Further, partial deletion of the cytoplasmic tail of CD46 results in low bacterial binding, indicating that the cytoplasmic tail takes part in the process of establishing a stable interaction between N. gonorrhoeae and host cells.     

Epithelial cell responses induced upon adherence of pathogenic Neisseria

Neisseria meningitidis and Neisseria gonorrhoeae colonize human mucosal surfaces and cause sepsis/meningitis and gonorrhoea respectively. The first step in the infection process is pilus-mediated adhesion of the bacteria to epithelial cells, followed by host cell invasion. Adhesion of pathogenic Neisseria elicits multiple responses in host cells, including cellular signalling events, cytokine production and modulation of the eukaryotic cell surface. We used microarrays to assess the respective involvement of 375 human cytokine and adhesion related genes during adhesion of piliated and non-piliated N. gonorrhoeae, and piliated encapsulated N. meningitidis to the epithelial cell line ME-180. We identified 29 differentially regulated genes not previously reported to respond to neisserial infections, many of which encode membrane proteins. Selected genes were further analysed by semiquantitative RT-PCR, and protein expression was examined by flow cytometry. We found that N. gonorrhoeae elicited a different inflammatory response than N. meningitidis and we also demonstrated that early adhesion events are responsible for the induction of specific genes. Our data create a new platform for elucidating the interaction between pathogenic Neisseria and target cells.     

山羊β-casein位点打靶载体在乳腺上皮细胞中的表达研究

以本地山羊基因组DNA为模板,通过长链PCR扩增出山羊β-casein上游包括启动子,外显子1及部分外显子2的6.1kb的调控序列及下游3.3kb的序列,将来自质粒pCDNA3的neo基因以及来自质粒pNEOZTK-2的tk基因,经克隆重组后构建了本地山羊乳腺特异性定点打靶载体,并在其中克隆人乳铁蛋白mini基因,采用脂质体法转染小鼠乳腺上皮癌化细胞系C127,以进行打靶载体的表达功能检测,双夹心ELISA测得诱导液中乳铁蛋白表达量为0.2μg/mL,Western-blot显示重组蛋白分子量比标准品略小,约为76kD,结果说明本载体能够指导外源基因在动物乳腺细胞内正确表达。     

Derepression of a mouse alpha-fetoprotein expression vector in COS-1 cells by amplification of specific cis-acting sequences of the AFP promoter.

The existence of trans-acting regulatory factors has been demonstrated by in vivo competition with cis-acting sequences from both viral and eukaryotic genomes. Plasmids containing a functional SV40 origin of replication when transfected into permissive SV40 T-antigen producing COS-1 cells will amplify to high copy numbers (5,000 to 10,000) without inflicting toxic effects upon the host cell. This amplification vector (pSVori) has been used to amplify cis-acting regulatory elements which can act as competitors for positive and negative trans-acting factors in vivo. Using this amplification system we conducted experiments to determine whether amplification of alpha-fetoprotein (AFP) and albumin cis-acting promoter sequences could activate a corresponding co-transfected AFP-promoter-CAT or Alb-promoter-CAT expression vector in COS-1 cells. We used pMoMLV(-1009)AFPcat, or p(-308)Albcat-MoMLV as reporter genes and pSVori to amplify specific promoter sequences of the AFP or albumin promoter. Our experiments indicated that amplification of a region from -53 to -202 of the AFP promoter resulted in the activation of the pMoMLV(-1009)AFPcat and p(-308)Albcat-MoMLV expression vectors in COS-1 cells. Surprisingly, amplification of the albumin promoter sequences failed to activate either the pMoMLV(-1009)AFPcat or p(-308)Albcat-MoMLV plasmids.     

Expression in monkey cells of the missing enzyme in L-ascorbic acid biosynthesis, L-gulono-gamma-lactone oxidase

L-Gulono-gamma-lactone oxidase (GLO), an enzyme that is missing in scurvy-prone animals, was produced in COS-1 cells by transfection with a minigene constructed from pSVL vector and rat GLO cDNA. A functional GLO protein was expressed, which was indistinguishable from rat GLO in molecular size. The microsomes obtained from the transfected COS-1 cells showed GLO activity comparable to that in rat liver microsomes.     

pcDNA3.1（＋）-LYVE-1真核表达质粒的构建及其在COS-7细胞中的表达

目的 构建人淋巴管内皮细胞特异标志物LYVE-1融合基因表达质粒,观察其在COS-7细胞中的表达,为进一步探讨该标志物在肿瘤淋巴转移中的作用提供工具.方法 从本院结肠癌根治术患者术所取组织中的淋巴结抽提总RNA,RT-PCR扩增LYVE-1基因片段,并将其插入pMD19-T Simple Vector进行测序,鉴定正确后构建pcDNA3.1（＋）-LYVE-1并转染COS-7细胞,RT-PCR、Western印迹检测目的 蛋白表达,间接免疫荧光检测该基因表达在COS-7细胞上.结果 成功获取了人淋巴管内皮细胞特异标志物LYVE-1全长cDNA,构建了其真核表达载体pcDNA3.1（＋）-LYVE-1,转染COS-7细胞后检测出目的 蛋白的表达,并且证明该基因表达在细胞上.结论 成功构建了pcDNA3.1（＋）-LYVE-1重组质粒,为进一步研究LYVE-1在肿瘤淋巴管转移中的功能提供了重要的实验材料.     

牛γ 干扰素的表达及其抗病毒活性测定

通过RT-PCR从经ConA刺激诱导的奶牛脾脏淋巴细胞总RNA中扩增出牛γ干扰素 (BoIFN-γ) cDNA,克隆到真核载体pVAX1中,测序结果显示pVAX1中的插入序列BoIFN-γ基因与已报道序列一致。用重组质粒pVAX1-BoIFN-γ转染COS-7细胞并进行间接免疫荧光试验鉴定,结果显示BoIFN-γ在COS-7细胞中得到成功表达。将BoIFN-γ基因克隆到原核表达质粒pET-30a(+)、pGEX-6p-1后,分别转化重组表达菌BL21(DE3)、BL21后,通过对表达条件的优化,SDS-P     

人呼吸道合胞病毒RNA聚合酶复合体蛋白N、P的表达鉴定

本研究根据编码A亚型人呼吸道合胞病毒(HumanRespiratorySyncytialVirus,HRSV)核壳体蛋白(Nucleocapsidprotein,N)和磷蛋白(phosphoprotein,P)的基因序列,各设计一对特异性的引物,应用RT-PCR技术,从感染HRSV的HEp-2细胞中扩增获得n和p的基因片断,克隆至真核表达载体pcDNA3.1( )。获得的重组质粒通过脂质体Lipofectamine2000转染COS-7细胞,72h后再用Westernblot鉴定蛋白的表达。结果显示真核表达载体pcDNA3.1( )/N和pcDNA3.1( )/P的限制性内切酶分析结果与预期一致,基因序列分析显示没有发生无义突变,利用蛋白印记方法也检测到了N和P的特异性条带。于是我们认为成功构建了含有HRSVN和P编码基因的真核表达载体,在真核细胞内能顺利表达。为进一步开展HRSV反向遗传学等研究奠定了基础。     

小鼠脂联素与绿色荧光蛋白融合基因表达载体的构建及在COS-7细胞中的表达

以绿色荧光蛋白(GFP)基因(gfp)为报告基因,构建小鼠脂联素(mADPN)基因(mAd)与gfp的融合基因mAd/gfp表达载体pCI-neo-apoEHCR-hAATp-mAd-gfp,脂质体法转染体外培养的COS-7细胞,荧光显微镜观察GFP在细胞中的表达可间接反映mADPN的表达,并通过RT-PCR在核酸水平进一步确证mAd的表达.荧光显微镜观察及RT-PCR结果均证明mADPN在COS-7细胞中获得了高效表达,表明mADPN重组表达载体pCI-neo-apoEHCR-hAATp-mAd可以在真核细胞COS-7中高效表达mADPN,为进一步探讨mAd在小鼠体内的表达提供了可行性依据.